Skip to main content
Top
Published in: Skeletal Radiology 1/2007

01-06-2007 | Case Report

Hyperphosphatasia with massive osteoectasia: a 45-year follow-up

Authors: E. F. McCarthy, G. H. Sack

Published in: Skeletal Radiology | Special Issue 1/2007

Login to get access

Abstract

Hyperphosphatasia is a heterogeneous group of disorders characterized by a generalized skeletal disease and increased alkaline phosphatase. Increased bone remodeling secondary to increased osteoclastic activity appears to be the underlying feature of these disorders. These disorders include juvenile Paget’s disease, expansile skeletal hyperphosphatasia, hyperostosis generalisata with striations, and Camurati-Engelmann’s disease, type II. The genetic mutations for a number of these disorders have been identified. We present a patient with congenital hyperphosphatasia whose clinical and radiographic features were somewhat different from these other well-defined syndromes. The patient was followed for 45 years until his death of at age 49. The patient had massive osteoectasia with dense striations involving the entire shaft of his long bones. His spine, pelvis, short tubular bones, and calvarium were also involved. He suffered hearing loss and optic atrophy, but he kept his teeth throughout his life. He was tall with a marfanoid habitus, and he had hypogonadism and hypothyroidism. There was no evidence of mental retardation, and other laboratory studies where within normal limits. This case, as well as other manifestations of hyperphosphatasia, attests to the complexity of the bone remodeling system.
Literature
1.
go back to reference Bakwin H, Eiger M. Fragile bones and macrocranium. J Pediatr 1956; 49(5):558–64.CrossRef Bakwin H, Eiger M. Fragile bones and macrocranium. J Pediatr 1956; 49(5):558–64.CrossRef
2.
go back to reference Whyte M. Heritable metabolic and dysplastic bone diseases. Endocrinol Metab Clin North Am 1990; 19(1):133–73.CrossRef Whyte M. Heritable metabolic and dysplastic bone diseases. Endocrinol Metab Clin North Am 1990; 19(1):133–73.CrossRef
3.
go back to reference van Hul W. Recent progress in the molecular genetics of sclerosing bone dysplasias. Pediatr Pathol Mol Med 2003; 22:11–22.CrossRef van Hul W. Recent progress in the molecular genetics of sclerosing bone dysplasias. Pediatr Pathol Mol Med 2003; 22:11–22.CrossRef
4.
go back to reference Ghadami M, Makita Y, Yoshida K, Nishimura G, Fukushima Y, Wakui K et al. Genetic mapping of the Camurati-Engelmann disease locus to chromosome 19q13.1–q13.3. Am J Hum Genet 2000; 66:143–7.CrossRef Ghadami M, Makita Y, Yoshida K, Nishimura G, Fukushima Y, Wakui K et al. Genetic mapping of the Camurati-Engelmann disease locus to chromosome 19q13.1–q13.3. Am J Hum Genet 2000; 66:143–7.CrossRef
5.
go back to reference Cundy T. Idiopathic hyperphosphatasia. Semin Musculoskelet Radiol 2002; 6(4):307–12.CrossRef Cundy T. Idiopathic hyperphosphatasia. Semin Musculoskelet Radiol 2002; 6(4):307–12.CrossRef
6.
go back to reference Middleton-Hardie C, Zhu Q, Cundy H, Lin J, Callon K, Cheung Tong P et al. Deletion of Aspartate 182 in OPG causes juvenile Paget’s disease by impairing both protein secretion and binding to RANKL. J Bone Miner Res 2006; 21(3):438–45.CrossRef Middleton-Hardie C, Zhu Q, Cundy H, Lin J, Callon K, Cheung Tong P et al. Deletion of Aspartate 182 in OPG causes juvenile Paget’s disease by impairing both protein secretion and binding to RANKL. J Bone Miner Res 2006; 21(3):438–45.CrossRef
7.
go back to reference Cundy T, Hegde M, Naot D, Chong B, King A, Wallace R et al. A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotype. Hum Mol Gen 2002; 11(18):2119–27.CrossRef Cundy T, Hegde M, Naot D, Chong B, King A, Wallace R et al. A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotype. Hum Mol Gen 2002; 11(18):2119–27.CrossRef
8.
go back to reference Whyte M, Obrecht S, Finnegan P, Jones J, Podgornik M, McAlister W et al. Osteoprotegerin deficiency and juvenile Paget’s disease. N Eng J Med 2002; 347(3):175–84.CrossRef Whyte M, Obrecht S, Finnegan P, Jones J, Podgornik M, McAlister W et al. Osteoprotegerin deficiency and juvenile Paget’s disease. N Eng J Med 2002; 347(3):175–84.CrossRef
9.
go back to reference Whyte M, Mills B, Reinus W, Podgornik M, Roodman G, Gannon F et al. Expansile skeletal hyperphosphatasia: a new familial metabolic bone disease. J Bone Miner Res 2000; 15(12):2330–44.CrossRef Whyte M, Mills B, Reinus W, Podgornik M, Roodman G, Gannon F et al. Expansile skeletal hyperphosphatasia: a new familial metabolic bone disease. J Bone Miner Res 2000; 15(12):2330–44.CrossRef
10.
go back to reference Whyte M, Hughes A. Expansile skeletal hyperphosphatasia is caused by a 15-base pair tandem duplication in TNFRSF11A encoding RANK and is allelic to familial expansile osteolysis. J Bone Miner Res 2002; 17(1):26–9.CrossRef Whyte M, Hughes A. Expansile skeletal hyperphosphatasia is caused by a 15-base pair tandem duplication in TNFRSF11A encoding RANK and is allelic to familial expansile osteolysis. J Bone Miner Res 2002; 17(1):26–9.CrossRef
11.
go back to reference Hughes A, Ralston S, Marken J, Bell C, MacPherson H, Wallace R et al. Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis. Nat Genet 2000; 24:45–8.CrossRef Hughes A, Ralston S, Marken J, Bell C, MacPherson H, Wallace R et al. Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis. Nat Genet 2000; 24:45–8.CrossRef
12.
go back to reference Osterberg P, Wallace R, Adams D, Crone R, Dickson G, Kanis J et al. Familial expansile osteolytis: a new dysplasia. J Bone Joint Surg Br 1988; 70(2):255–60.CrossRef Osterberg P, Wallace R, Adams D, Crone R, Dickson G, Kanis J et al. Familial expansile osteolytis: a new dysplasia. J Bone Joint Surg Br 1988; 70(2):255–60.CrossRef
13.
go back to reference Marik I, Marikova A, Hyankova E, Kozlowski K. Familial expansile osteolysis-not exclusively an adult disorder. Skeletal Radiol 2006; published online. Marik I, Marikova A, Hyankova E, Kozlowski K. Familial expansile osteolysis-not exclusively an adult disorder. Skeletal Radiol 2006; published online.
14.
go back to reference Fujimoto H, Nishimura G, Tsumarai Y, Nosaka K, Kanisawa S, Ohba S et al. Hyperostosis generalisata with striations of the bones: report of a female case and a review of the literature. Skeletal Radiol 1999; 28:460–4.CrossRef Fujimoto H, Nishimura G, Tsumarai Y, Nosaka K, Kanisawa S, Ohba S et al. Hyperostosis generalisata with striations of the bones: report of a female case and a review of the literature. Skeletal Radiol 1999; 28:460–4.CrossRef
15.
go back to reference Nishimura G, Nishimura H, Tanaka Y, Makita Y, Ikegawa S, Ghadami M et al. Camurati-Engelmann disease type II: progressive dyaphyseal dysplasia with striations of the bones. Am J Med Genet 2002; 107:5–11.CrossRef Nishimura G, Nishimura H, Tanaka Y, Makita Y, Ikegawa S, Ghadami M et al. Camurati-Engelmann disease type II: progressive dyaphyseal dysplasia with striations of the bones. Am J Med Genet 2002; 107:5–11.CrossRef
Metadata
Title
Hyperphosphatasia with massive osteoectasia: a 45-year follow-up
Authors
E. F. McCarthy
G. H. Sack
Publication date
01-06-2007
Publisher
Springer Berlin Heidelberg
Published in
Skeletal Radiology / Issue Special Issue 1/2007
Print ISSN: 0364-2348
Electronic ISSN: 1432-2161
DOI
https://doi.org/10.1007/s00256-006-0176-3

Other articles of this Special Issue 1/2007

Skeletal Radiology 1/2007 Go to the issue